“She wants to join my son at his private liberal-arts college that costs $83,000 a year.”

The French pharmaceutical giant will work with Novavax to commercialize its existing COVI-19 vaccine and help develop a new combined vaccine for both COVID-19 and Influenza

The U.S. stock market’s climb this year probably has stalled for the rest of 2024, even as investors remain optimistic that companies stand to benefit from the adoption of artificial intelligence, according to Goldman Sachs Group’s David Kostin.

The cryptocurrency industry’s spending on Washington lobbying rose to a fresh record last year, while it’s started out 2024 with more sizable spending to influence the U.S. government.

Oil futures are on track for weekly gains, taking back some of the ground lost last week as fears of a broader Middle East war faded.

The FDA cited administrative constraints for the delay, Cambridge, Mass.-based Moderna said in a statement.